Normal Saline Infusion After Intravenous Thrombolysis in Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 752 participants.

Also called NCT07497542

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 752 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07497542
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07497542. Randomized; double masking; primary purpose treatment. Start 2026-04 (anticipated); primary completion 2029-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Normal Saline Infusion After Intravenous Thrombolysis in Stroke
Condition
Brain Infarction
Intervention (Drug)
normal saline
Intervention (Drug)
normal saline
Lead sponsor
Tianjin Medical University General Hospital (class: other)

Record details

Record id
cardio:ct-nct07497542
Content hash
f5e2a6602f0a9588e251fe90e3c32eb32e77c519a97110663e1fc56a58c624c3